Cargando…

Indirubin, a small molecular deriving from connectivity map (CMAP) screening, ameliorates obesity-induced metabolic dysfunction by enhancing brown adipose thermogenesis and white adipose browning

BACKGROUND: Obesity occurs when the body’s energy intake is constantly greater than its energy consumption and the pharmacological enhancing the activity of brown adipose tissue (BAT) and (or) browning of white adipose tissue (WAT) has been considered promising strategies to treat obesity. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Gang, Sun, Honglin, Liu, Jun-li, Dong, Kai, Liu, Junli, Zhang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076951/
https://www.ncbi.nlm.nih.gov/pubmed/32190098
http://dx.doi.org/10.1186/s12986-020-00440-4
_version_ 1783507326637965312
author Wei, Gang
Sun, Honglin
Liu, Jun-li
Dong, Kai
Liu, Junli
Zhang, Min
author_facet Wei, Gang
Sun, Honglin
Liu, Jun-li
Dong, Kai
Liu, Junli
Zhang, Min
author_sort Wei, Gang
collection PubMed
description BACKGROUND: Obesity occurs when the body’s energy intake is constantly greater than its energy consumption and the pharmacological enhancing the activity of brown adipose tissue (BAT) and (or) browning of white adipose tissue (WAT) has been considered promising strategies to treat obesity. METHODS: In this study, we took a multi-pronged approach to screen UCP1 activators, including in silico predictions, in vitro assays, as well as in vivo experiments. RESULTS: Base on Connectivity MAP (CMAP) screening, we obtained multiple drugs that possess a remarkably correlating gene expression pattern to that of enhancing activity in BAT and (or) sWAT signature. Particularly, we focused on a previously unreported drug-indirubin, a compound obtained from the Indigo plant, which is now mainly used for the treatment of chronic myelogenous leukemia (CML). In the current study, our results shown that indirubin could enhance the BAT activity, as evidenced by up-regulated Ucp1 expression and enhanced mitochondrial respiratory function in vitro cellular model. Furthermore, indirubin treatment restrained high-fat diet (HFD)-induced body weight gain, improved glucose homeostasis and ameliorated hepatic steatosis which were associated with the increase of energy expenditure in the mice model. Moreover, we revealed that indirubin treatment increased BAT activity by promoting thermogenesis and mitochondrial biogenesis in BAT and induced browning of subcutaneous inguinal white adipose tissue (sWAT) of mice under HFD. Besides, our results indicated that indirubin induced UCP1 expression in brown adipocytes, at least in part, via activation of PKA and p38MAPK signaling pathways. CONCLUSIONS: Our results clearly show that as an effective BAT (as well as beige cells) activator, indirubin may have a protective effect on the prevention and treatment of obesity and its complications.
format Online
Article
Text
id pubmed-7076951
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70769512020-03-18 Indirubin, a small molecular deriving from connectivity map (CMAP) screening, ameliorates obesity-induced metabolic dysfunction by enhancing brown adipose thermogenesis and white adipose browning Wei, Gang Sun, Honglin Liu, Jun-li Dong, Kai Liu, Junli Zhang, Min Nutr Metab (Lond) Research BACKGROUND: Obesity occurs when the body’s energy intake is constantly greater than its energy consumption and the pharmacological enhancing the activity of brown adipose tissue (BAT) and (or) browning of white adipose tissue (WAT) has been considered promising strategies to treat obesity. METHODS: In this study, we took a multi-pronged approach to screen UCP1 activators, including in silico predictions, in vitro assays, as well as in vivo experiments. RESULTS: Base on Connectivity MAP (CMAP) screening, we obtained multiple drugs that possess a remarkably correlating gene expression pattern to that of enhancing activity in BAT and (or) sWAT signature. Particularly, we focused on a previously unreported drug-indirubin, a compound obtained from the Indigo plant, which is now mainly used for the treatment of chronic myelogenous leukemia (CML). In the current study, our results shown that indirubin could enhance the BAT activity, as evidenced by up-regulated Ucp1 expression and enhanced mitochondrial respiratory function in vitro cellular model. Furthermore, indirubin treatment restrained high-fat diet (HFD)-induced body weight gain, improved glucose homeostasis and ameliorated hepatic steatosis which were associated with the increase of energy expenditure in the mice model. Moreover, we revealed that indirubin treatment increased BAT activity by promoting thermogenesis and mitochondrial biogenesis in BAT and induced browning of subcutaneous inguinal white adipose tissue (sWAT) of mice under HFD. Besides, our results indicated that indirubin induced UCP1 expression in brown adipocytes, at least in part, via activation of PKA and p38MAPK signaling pathways. CONCLUSIONS: Our results clearly show that as an effective BAT (as well as beige cells) activator, indirubin may have a protective effect on the prevention and treatment of obesity and its complications. BioMed Central 2020-03-16 /pmc/articles/PMC7076951/ /pubmed/32190098 http://dx.doi.org/10.1186/s12986-020-00440-4 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wei, Gang
Sun, Honglin
Liu, Jun-li
Dong, Kai
Liu, Junli
Zhang, Min
Indirubin, a small molecular deriving from connectivity map (CMAP) screening, ameliorates obesity-induced metabolic dysfunction by enhancing brown adipose thermogenesis and white adipose browning
title Indirubin, a small molecular deriving from connectivity map (CMAP) screening, ameliorates obesity-induced metabolic dysfunction by enhancing brown adipose thermogenesis and white adipose browning
title_full Indirubin, a small molecular deriving from connectivity map (CMAP) screening, ameliorates obesity-induced metabolic dysfunction by enhancing brown adipose thermogenesis and white adipose browning
title_fullStr Indirubin, a small molecular deriving from connectivity map (CMAP) screening, ameliorates obesity-induced metabolic dysfunction by enhancing brown adipose thermogenesis and white adipose browning
title_full_unstemmed Indirubin, a small molecular deriving from connectivity map (CMAP) screening, ameliorates obesity-induced metabolic dysfunction by enhancing brown adipose thermogenesis and white adipose browning
title_short Indirubin, a small molecular deriving from connectivity map (CMAP) screening, ameliorates obesity-induced metabolic dysfunction by enhancing brown adipose thermogenesis and white adipose browning
title_sort indirubin, a small molecular deriving from connectivity map (cmap) screening, ameliorates obesity-induced metabolic dysfunction by enhancing brown adipose thermogenesis and white adipose browning
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076951/
https://www.ncbi.nlm.nih.gov/pubmed/32190098
http://dx.doi.org/10.1186/s12986-020-00440-4
work_keys_str_mv AT weigang indirubinasmallmolecularderivingfromconnectivitymapcmapscreeningamelioratesobesityinducedmetabolicdysfunctionbyenhancingbrownadiposethermogenesisandwhiteadiposebrowning
AT sunhonglin indirubinasmallmolecularderivingfromconnectivitymapcmapscreeningamelioratesobesityinducedmetabolicdysfunctionbyenhancingbrownadiposethermogenesisandwhiteadiposebrowning
AT liujunli indirubinasmallmolecularderivingfromconnectivitymapcmapscreeningamelioratesobesityinducedmetabolicdysfunctionbyenhancingbrownadiposethermogenesisandwhiteadiposebrowning
AT dongkai indirubinasmallmolecularderivingfromconnectivitymapcmapscreeningamelioratesobesityinducedmetabolicdysfunctionbyenhancingbrownadiposethermogenesisandwhiteadiposebrowning
AT liujunli indirubinasmallmolecularderivingfromconnectivitymapcmapscreeningamelioratesobesityinducedmetabolicdysfunctionbyenhancingbrownadiposethermogenesisandwhiteadiposebrowning
AT zhangmin indirubinasmallmolecularderivingfromconnectivitymapcmapscreeningamelioratesobesityinducedmetabolicdysfunctionbyenhancingbrownadiposethermogenesisandwhiteadiposebrowning